310 related articles for article (PubMed ID: 23704211)
21. Myeloid Derived Suppressor Cells: Key Drivers of Immunosuppression in Ovarian Cancer.
Baert T; Vankerckhoven A; Riva M; Van Hoylandt A; Thirion G; Holger G; Mathivet T; Vergote I; Coosemans A
Front Immunol; 2019; 10():1273. PubMed ID: 31214202
[TBL] [Abstract][Full Text] [Related]
22. Programmed cell death ligand 1 disruption by clustered regularly interspaced short palindromic repeats/Cas9-genome editing promotes antitumor immunity and suppresses ovarian cancer progression.
Yahata T; Mizoguchi M; Kimura A; Orimo T; Toujima S; Kuninaka Y; Nosaka M; Ishida Y; Sasaki I; Fukuda-Ohta Y; Hemmi H; Iwahashi N; Noguchi T; Kaisho T; Kondo T; Ino K
Cancer Sci; 2019 Apr; 110(4):1279-1292. PubMed ID: 30702189
[TBL] [Abstract][Full Text] [Related]
23. Differential CD86/B7-2 expression and cytokine secretion induced by Toxoplasma gondii in macrophages from resistant or susceptible BALB H-2 congenic mice.
Fischer HG; Dörfler R; Schade B; Hadding U
Int Immunol; 1999 Mar; 11(3):341-9. PubMed ID: 10221646
[TBL] [Abstract][Full Text] [Related]
24. NK cells help to induce CD8(+)-T-cell immunity against Toxoplasma gondii in the absence of CD4(+) T cells.
Combe CL; Curiel TJ; Moretto MM; Khan IA
Infect Immun; 2005 Aug; 73(8):4913-21. PubMed ID: 16041005
[TBL] [Abstract][Full Text] [Related]
25. Suppression of CD4 T-Cells in the spleen of mice infected with Toxoplasma gondii KI-1 tachyzoites.
Kim WH; Shin EH; Kim JL; Yu SY; Jung BK; Chai JY
Korean J Parasitol; 2010 Dec; 48(4):325-9. PubMed ID: 21234236
[TBL] [Abstract][Full Text] [Related]
26. IL-12 triggers a programmatic change in dysfunctional myeloid-derived cells within mouse tumors.
Kerkar SP; Goldszmid RS; Muranski P; Chinnasamy D; Yu Z; Reger RN; Leonardi AJ; Morgan RA; Wang E; Marincola FM; Trinchieri G; Rosenberg SA; Restifo NP
J Clin Invest; 2011 Dec; 121(12):4746-57. PubMed ID: 22056381
[TBL] [Abstract][Full Text] [Related]
27. A uracil auxotroph Toxoplasma gondii exerting immunomodulation to inhibit breast cancer growth and metastasis.
Xu LQ; Yao LJ; Jiang D; Zhou LJ; Chen M; Liao WZ; Zou WH; Peng HJ
Parasit Vectors; 2021 Dec; 14(1):601. PubMed ID: 34895326
[TBL] [Abstract][Full Text] [Related]
28. RPN13/ADRM1 inhibitor reverses immunosuppression by myeloid-derived suppressor cells.
Soong RS; Anchoori RK; Yang B; Yang A; Tseng SH; He L; Tsai YC; Roden RB; Hung CF
Oncotarget; 2016 Oct; 7(42):68489-68502. PubMed ID: 27655678
[TBL] [Abstract][Full Text] [Related]
29. Thrombin inhibition and cisplatin block tumor progression in ovarian cancer by alleviating the immunosuppressive microenvironment.
Alexander ET; Minton AR; Peters MC; van Ryn J; Gilmour SK
Oncotarget; 2016 Dec; 7(51):85291-85305. PubMed ID: 27852034
[TBL] [Abstract][Full Text] [Related]
30. Therapeutic PD-1 pathway blockade augments with other modalities of immunotherapy T-cell function to prevent immune decline in ovarian cancer.
Duraiswamy J; Freeman GJ; Coukos G
Cancer Res; 2013 Dec; 73(23):6900-12. PubMed ID: 23975756
[TBL] [Abstract][Full Text] [Related]
31. Effective Targeting of TAG72
Murad JP; Kozlowska AK; Lee HJ; Ramamurthy M; Chang WC; Yazaki P; Colcher D; Shively J; Cristea M; Forman SJ; Priceman SJ
Front Immunol; 2018; 9():2268. PubMed ID: 30510550
[TBL] [Abstract][Full Text] [Related]
32. Recombinant
Deng W; Lira V; Hudson TE; Lemmens EE; Hanson WG; Flores R; Barajas G; Katibah GE; Desbien AL; Lauer P; Leong ML; Portnoy DA; Dubensky TW
Proc Natl Acad Sci U S A; 2018 Aug; 115(32):8179-8184. PubMed ID: 30038013
[TBL] [Abstract][Full Text] [Related]
33. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
[TBL] [Abstract][Full Text] [Related]
34. Favorable alteration of tumor microenvironment by immunomodulatory cytokines for efficient T-cell therapy in solid tumors.
Tähtinen S; Kaikkonen S; Merisalo-Soikkeli M; Grönberg-Vähä-Koskela S; Kanerva A; Parviainen S; Vähä-Koskela M; Hemminki A
PLoS One; 2015; 10(6):e0131242. PubMed ID: 26107883
[TBL] [Abstract][Full Text] [Related]
35. CDK4/6 inhibition promotes immune infiltration in ovarian cancer and synergizes with PD-1 blockade in a B cell-dependent manner.
Zhang QF; Li J; Jiang K; Wang R; Ge JL; Yang H; Liu SJ; Jia LT; Wang L; Chen BL
Theranostics; 2020; 10(23):10619-10633. PubMed ID: 32929370
[TBL] [Abstract][Full Text] [Related]
36. Subcellular antigen location influences T-cell activation during acute infection with Toxoplasma gondii.
Gregg B; Dzierszinski F; Tait E; Jordan KA; Hunter CA; Roos DS
PLoS One; 2011; 6(7):e22936. PubMed ID: 21829561
[TBL] [Abstract][Full Text] [Related]
37. Improvement of a dendritic cell-based therapeutic cancer vaccine with components of Toxoplasma gondii.
Motamedi M; Arab S; Moazzeni SM; Khamis Abadi M; Hadjati J
Clin Vaccine Immunol; 2009 Oct; 16(10):1393-8. PubMed ID: 19656994
[TBL] [Abstract][Full Text] [Related]
38. Recombinant attenuated Toxoplasma gondii expressing the Plasmodium yoelii circumsporozoite protein provides highly effective priming for CD8+ T cell-dependent protective immunity against malaria.
Charest H; Sedegah M; Yap GS; Gazzinelli RT; Caspar P; Hoffman SL; Sher A
J Immunol; 2000 Aug; 165(4):2084-92. PubMed ID: 10925293
[TBL] [Abstract][Full Text] [Related]
39. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments.
Sprague L; Muccioli M; Pate M; Singh M; Xiong C; Ostermann A; Niese B; Li Y; Li Y; Courreges MC; Benencia F
Exp Cell Res; 2014 Apr; 323(1):7-27. PubMed ID: 24569142
[TBL] [Abstract][Full Text] [Related]
40. B7-H3 Suppresses Antitumor Immunity via the CCL2-CCR2-M2 Macrophage Axis and Contributes to Ovarian Cancer Progression.
Miyamoto T; Murakami R; Hamanishi J; Tanigaki K; Hosoe Y; Mise N; Takamatsu S; Mise Y; Ukita M; Taki M; Yamanoi K; Horikawa N; Abiko K; Yamaguchi K; Baba T; Matsumura N; Mandai M
Cancer Immunol Res; 2022 Jan; 10(1):56-69. PubMed ID: 34799346
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
